Prudential Financial Inc Adma Biologics, Inc. Transaction History

Prudential Financial Inc

$80 Billion
Q3 2025

A detailed history of Prudential Financial Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 441,830 shares of ADMA stock, worth $6.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

441,830

Previous 498,700 11.4%

Holding current value

$6.56 Million

Previous $9.08 Million 28.68%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$14.66 - $19.91 $833,714 - $1.13 Million	-56,870 Reduced 11.4%	441,830 $6.48 Million
Q2 2025 Aug 12, 2025	BUY	$17.6 - $24.51 $11,704 - $16,299	665 Added 0.13%	498,700 $9.08 Million
Q1 2025 May 13, 2025	SELL	$15.44 - $20.61 $407,538 - $544,000	-26,395 Reduced 5.03%	498,035 $9.88 Million
Q4 2024 Feb 11, 2025	BUY	$15.62 - $22.62 $92,111 - $133,390	5,897 Added 1.14%	524,430 $8.99 Million
Q3 2024 Nov 13, 2024	BUY	$11.21 - $20.03 $1.38 Million - $2.46 Million	122,959 Added 31.08%	518,533 $10.4 Million
Q2 2024 Aug 13, 2024	BUY	$5.98 - $11.18 $2.15 Million - $4.02 Million	359,238 Added 988.66%	395,574 $4.42 Million
Q1 2024 May 14, 2024	BUY	$4.4 - $6.74 $100,082 - $153,308	22,746 Added 167.37%	36,336 $239,000
Q4 2023 Feb 13, 2024	BUY	$3.08 - $4.52 $1,694 - $2,485	550 Added 4.22%	13,590 $61,000
Q2 2023 Aug 11, 2023	BUY	$3.12 - $4.22 $3,057 - $4,135	980 Added 8.13%	13,040 $48,000
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $933 - $1,199	310 Added 2.64%	12,060 $39,000
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $9,139 - $14,356	-3,700 Reduced 23.95%	11,750 $0
Q3 2022 Nov 04, 2022	SELL	$2.03 - $2.86 $34,916 - $49,192	-17,200 Reduced 52.68%	15,450 $38,000
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $46,689 - $71,830	32,650 New	32,650 $65,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.07 $19,492 - $26,721	-12,909 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$1.67 - $2.95 $3,306 - $5,841	1,980 Added 18.12%	12,909 $23,000
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $22,295 - $40,874	10,929 New	10,929 $26,000

Others Institutions Holding ADMA

# of Institutions

389

Shares Held

196M

Call Options Held

2.11M

Put Options Held

1.56M

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $2.91B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Adma Biologics, Inc. Transaction History